UNSPSC 51373005: Moxazocine

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51373005

Definition

This classification denotes an analgesic agent with the molecular formula C18H25NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BNB57S7DWT, chemically known as 2,6-methano-3-benzazocin-8-ol, 3-(cyclopropyl-methyl)-1,2,3,4,5,6-hexahydro-11-methoxy-6-methyl-,(2r-(2 alpha, 6 alpha, 11r*))-; but generally known as moxazocine, which bears US NIH Compound Identifier 3047776. European Medicines Agency schedules Moxazocine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09083MIG.

Read the full definition

The term MOXAZOCINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). MOXAZOCINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule moxazocine under HS 29333999 and SITC 51574. As of Q4 2014, MOXAZOCINE remains the US FDA Preferred Term for this commodity. Moxazocine bears US NLM identifiers UMLS ID C2983815 and NCI Concept Code C90644. SMILES: O(C1C2(CCN(C1CC1C2CC(O)CC1)CC1CC1)C)C.

About UNSPSC 51373005

UNSPSC 51373005 Moxazocine is a Commodity code that nominally describes a specific pharmaceutical compound, but the single recent state and local opportunity tagged to this code does not reflect pharmaceutical procurement in the traditional sense. Seminole County, Florida posted an IFB in June 2026 for naloxone and drug deactivation systems—harm-reduction and emergency-response medical supplies rather than moxazocine itself. The mismatch suggests either a classification error in the county's procurement tagging or that the code is being used inconsistently across state and local agencies. Based on the available recent-opportunities record, this code shows little relevant activity for pharmaceutical vendors seeking predictable state and local demand.

Seminole County's IFB60459723LAS, due July 26, 2023 (note: the posted date of June 30, 2026 appears inconsistent with the response deadline), called for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement required electronic bid submission through the county's e-procurement portal, inclusion of all shipping and delivery costs, drug-free workplace certification, and E-Verify compliance. The contract carried a two-year initial term with an optional one-year renewal and included a three-month probationary period allowing termination at will. The source indicates potential FEMA funding and associated federal compliance obligations. No other state or local jurisdictions appear in the recent-opportunities record under this code, and no geographic concentration pattern emerges. Vendors should verify actual code assignment with the issuing jurisdiction before pursuing opportunities tagged to 51373005, as the current tagging may not reflect the code's intended scope.

Quick answers

What is UNSPSC 51373005?

UNSPSC 51373005 is Moxazocine, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51373005?

UNSPSC 51373005 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51373005

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code